# Regions Financial Corp: financial statements, quarterly

RF · NYSE · CIK 1281761 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rf.md) · [Financials](/companies/rf/financials.md) · [Filings](/companies/rf/filings.md) · [Insiders](/companies/rf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [475](/filings/0001281761-23-000057.md) | [520 d](/filings/0001281761-24-000010.md) | [540](/filings/0001281761-24-000032.md) | [576](/filings/0001281761-24-000062.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [129](/filings/0001281761-24-000097.md) | [80.0 d](/filings/0001281761-26-000019.md) | [96.0](/filings/0001281761-25-000045.md) | [124](/filings/0001281761-25-000063.md) | [118](/filings/0001281761-25-000080.md) | [123 d](/filings/0001281761-26-000019.md) | [131](/filings/0001281761-26-000037.md) | [143](/filings/0001281761-26-000055.md) | [139](/filings/0001281761-25-000080.md) | [174 d](/filings/0001281761-26-000019.md) | [155](/filings/0001281761-26-000037.md) | [148](/filings/0001281761-26-000055.md) |
| Net income | $m | [490](/filings/0001281761-24-000097.md) | [391 d](/filings/0001281761-26-000019.md) | [368](/filings/0001281761-25-000045.md) | [501](/filings/0001281761-25-000080.md) | [490](/filings/0001281761-25-000080.md) | [534 d](/filings/0001281761-26-000019.md) | [490](/filings/0001281761-26-000055.md) | [563](/filings/0001281761-26-000055.md) | [569](/filings/0001281761-25-000080.md) | [534 d](/filings/0001281761-26-000019.md) | [559](/filings/0001281761-26-000055.md) | [570](/filings/0001281761-26-000055.md) |
| Diluted EPS | $ per share | [0.49](/filings/0001281761-24-000097.md) | not reported | [0.37](/filings/0001281761-25-000045.md) | [0.52](/filings/0001281761-25-000063.md) | [0.49](/filings/0001281761-25-000080.md) | not reported | [0.51](/filings/0001281761-26-000037.md) | [0.59](/filings/0001281761-26-000055.md) | [0.61](/filings/0001281761-25-000080.md) | not reported | [0.62](/filings/0001281761-26-000037.md) | [0.64](/filings/0001281761-26-000055.md) |
| Basic EPS | $ per share | [0.49](/filings/0001281761-24-000097.md) | not reported | [0.37](/filings/0001281761-25-000045.md) | [0.52](/filings/0001281761-25-000063.md) | [0.49](/filings/0001281761-25-000080.md) | not reported | [0.51](/filings/0001281761-26-000037.md) | [0.59](/filings/0001281761-26-000055.md) | [0.62](/filings/0001281761-25-000080.md) | not reported | [0.63](/filings/0001281761-26-000037.md) | [0.64](/filings/0001281761-26-000055.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [154](/filings/0001281761-23-000057.md) | [152](/filings/0001281761-25-000010.md) | [155](/filings/0001281761-24-000032.md) | [154](/filings/0001281761-24-000062.md) | [157](/filings/0001281761-24-000097.md) | [157](/filings/0001281761-26-000019.md) | [160](/filings/0001281761-25-000045.md) | [159](/filings/0001281761-25-000063.md) | [160](/filings/0001281761-25-000080.md) | [159](/filings/0001281761-26-000055.md) | [161](/filings/0001281761-26-000037.md) | [161](/filings/0001281761-26-000055.md) |
| Total liabilities | $bn | [137](/filings/0001281761-23-000057.md) | [135](/filings/0001281761-25-000010.md) | [138](/filings/0001281761-24-000032.md) | [137](/filings/0001281761-24-000062.md) | [139](/filings/0001281761-24-000097.md) | [139](/filings/0001281761-26-000019.md) | [141](/filings/0001281761-25-000045.md) | [141](/filings/0001281761-25-000063.md) | [141](/filings/0001281761-25-000080.md) | [140](/filings/0001281761-26-000055.md) | [142](/filings/0001281761-26-000037.md) | [142](/filings/0001281761-26-000055.md) |
| Long-term debt | $bn | [4.3](/filings/0001281761-23-000057.md) | [2.3](/filings/0001281761-25-000010.md) | [3.3](/filings/0001281761-24-000032.md) | [5.1](/filings/0001281761-24-000062.md) | [6.0](/filings/0001281761-24-000097.md) | [6.0](/filings/0001281761-26-000019.md) | [6.0](/filings/0001281761-25-000045.md) | [5.3](/filings/0001281761-25-000063.md) | [4.8](/filings/0001281761-25-000080.md) | [4.1](/filings/0001281761-26-000055.md) | [3.1](/filings/0001281761-26-000037.md) | [4.6](/filings/0001281761-26-000055.md) |
| Short-term borrowings | $bn | [2.0](/filings/0001281761-23-000057.md) | [0.0](/filings/0001281761-25-000010.md) | [1.0](/filings/0001281761-24-000032.md) | [0.5](/filings/0001281761-24-000062.md) | [1.5](/filings/0001281761-24-000097.md) | [0.5](/filings/0001281761-26-000019.md) | [0.0](/filings/0001281761-25-000045.md) | [0.0](/filings/0001281761-25-000063.md) | [1.3](/filings/0001281761-25-000080.md) | [0.8](/filings/0001281761-26-000055.md) | [3.2](/filings/0001281761-26-000037.md) | [3.0](/filings/0001281761-26-000055.md) |
| Shareholders' equity | $bn | [16.1](/filings/0001281761-24-000097.md) | [17.4](/filings/0001281761-26-000019.md) | [17.0](/filings/0001281761-25-000080.md) | [17.2](/filings/0001281761-25-000080.md) | [18.7](/filings/0001281761-25-000080.md) | [17.9](/filings/0001281761-26-000055.md) | [18.5](/filings/0001281761-26-000055.md) | [18.7](/filings/0001281761-26-000055.md) | [19.0](/filings/0001281761-25-000080.md) | [19.0](/filings/0001281761-26-000055.md) | [18.8](/filings/0001281761-26-000055.md) | [18.8](/filings/0001281761-26-000055.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [860 d](/filings/0001281761-24-000097.md) | [855 d](/filings/0001281761-26-000019.md) | [396](/filings/0001281761-25-000045.md) | [161 d](/filings/0001281761-25-000063.md) | [1,261 d](/filings/0001281761-25-000080.md) | [(220) d](/filings/0001281761-26-000019.md) | [1,066](/filings/0001281761-26-000037.md) | [573 d](/filings/0001281761-26-000055.md) | [861 d](/filings/0001281761-25-000080.md) | [(319) d](/filings/0001281761-26-000019.md) | [867](/filings/0001281761-26-000037.md) | [369 d](/filings/0001281761-26-000055.md) |
| Dividends paid | $m | [187 d](/filings/0001281761-24-000097.md) | [226 d](/filings/0001281761-26-000019.md) | [222](/filings/0001281761-25-000045.md) | [220 d](/filings/0001281761-25-000063.md) | [220 d](/filings/0001281761-25-000080.md) | [228 d](/filings/0001281761-26-000019.md) | [227](/filings/0001281761-26-000037.md) | [226 d](/filings/0001281761-26-000055.md) | [224 d](/filings/0001281761-25-000080.md) | [235 d](/filings/0001281761-26-000019.md) | [230](/filings/0001281761-26-000037.md) | [228 d](/filings/0001281761-26-000055.md) |
| Share repurchases | $m | [0.0 d](/filings/0001281761-24-000097.md) | [252 d](/filings/0001281761-26-000019.md) | [102](/filings/0001281761-25-000045.md) | [87.0 d](/filings/0001281761-25-000063.md) | [101 d](/filings/0001281761-25-000080.md) | [58.0 d](/filings/0001281761-26-000019.md) | [242](/filings/0001281761-26-000037.md) | [144 d](/filings/0001281761-26-000055.md) | [251 d](/filings/0001281761-25-000080.md) | [430 d](/filings/0001281761-26-000019.md) | [401](/filings/0001281761-26-000037.md) | [59.0 d](/filings/0001281761-26-000055.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [940](/filings/0001281761-23-000057.md) | [942](/filings/0001281761-24-000032.md) | [939](/filings/0001281761-24-000062.md) | [940](/filings/0001281761-24-000097.md) | [923](/filings/0001281761-25-000045.md) | [918](/filings/0001281761-25-000063.md) | [918](/filings/0001281761-25-000080.md) | [910](/filings/0001281761-26-000037.md) | [900](/filings/0001281761-26-000055.md) | [894](/filings/0001281761-25-000080.md) | [868](/filings/0001281761-26-000037.md) | [857](/filings/0001281761-26-000055.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 851,929,506 at 2026-08-05, from the cover of the [10-Q filed 2026-08-06](/filings/0001281761-26-000055.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.